Suscribirse

Dopaminergic effect of Alstonia scholaris Linn. R.Br. in experimentally induced anxiety - 03/07/13

Doi : 10.1016/j.biomag.2013.04.001 
Arulmozhi Sinnathambi a, , Papiya Mitra Mazumder b, Sathiyanarayanan Lohidasan c, Prasad Thakurdesai a
a Department of Pharmacology, Bharati Vidyapeeth University, Poona College of Pharmacy, Erandwane, Pune 411 038, Maharashtra, India 
b Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835 215, India 
c Department of Pharmaceutical Chemistry, Bharati Vidyapeeth University, Poona College of Pharmacy, Erandwane, Pune 411 038, Maharashtra, India 

Corresponding author. Department of Pharmacology, Bharati Vidyapeeth University, Poona College of Pharmacy, Erandwane, Pune-411 038, Maharashtra, India. Tel.: +91 93 71 08 5077.

Abstract

Aim of the study

The anti-anxiety activity of the ethanolic extract of leaves of Alstonia scholaris (Family: Apocynaceae) has been well established. The aim of the present study is to evaluate the anti-anxiety activity of the dichloromethane fraction (known as DCM) fractionated from ethanolic extract of leaves of A. scholaris (known as EEAS).

Materials and methods

DCM fraction (10 and 30mg/kg) was tested against various anti-anxiety models viz. elevated plus maze, open field, hole board, light dark test, mirror chamber and foot shock induced aggression models. The false positive results were overruled by actophotometer and rotarod tests. The change in brain monoamines was estimated. The possible dopaminergic effect was tested by haloperidol-induced catalepsy and 6-hydroxy dopamine induced Parkinsonism.

Results

The DCM fraction of EEAS was found to be significantly active in all the tested models of anxiety, which confirmed their anti-anxiety activity. Lack of significant change in locomotion test indicated that DCM did not have stimulant or sedative effects. There was also no significant change in the time spent in the rotarod, which indicated its lack of motor or muscle in coordination. Increase in brain dopamine levels and reversal of dopamine-induced catalepsy confirmed that the mechanism of anti-anxiety activity is mediated through dopamine. The effect of DCM in 6-hydroxy dopamine-induced anxiety was conclusive of its dopaminergic activity.

Conclusion

The present study suggests that DCM possess anti-anxiety and the apparent mechanism of action is through dopaminergic mediation.

El texto completo de este artículo está disponible en PDF.

Keywords : Anti-anxiety, Alstonia scholaris, Dopaminergic, Parkinsonism


Esquema


© 2013  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 3 - N° 2

P. 51-57 - avril 2013 Regresar al número
Artículo precedente Artículo precedente
  • Biochemical estimations of multidrug resistance (ferulic acid and paclitaxel) in non-small cells lung carcinoma cells in vitro
  • J.P. Jose Merlin, B. Venkadesh, R. Hussain, S.S. Rajan
| Artículo siguiente Artículo siguiente
  • Antiproliferative and apoptotic effects of naringin on diethylnitrosamine induced hepatocellular carcinoma in rats
  • Prabu Thangavel, Manju Vaiyapuri

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.